OVARIAN CLEAR CELL CARCINOMA

This adverse event was reported 39 times

OVARIAN CLEAR CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NORETHINDRONE AND ETHINYL ESTRADIOL 2 0.0017
1 LISOCABTAGENE MARALEUCEL 1 0.0011
2 INFLIXIMAB-AXXQ 1 0.0009
3 TOPOTECAN 3 0.0005
4 FINGOLIMOD HYDROCHLORIDE 1 0.0002
5 MICAFUNGIN SODIUM 1 0.0002
6 GEMCITABINE HYDROCHLORIDE 7 0.0001
7 BEVACIZUMAB 14 0.0001
8 PACLITAXEL 8 0.0001
9 PAZOPANIB HYDROCHLORIDE 2 0.0001
See all drugs enriched for association with OVARIAN CLEAR CELL CARCINOMA